Phase 2 Study of Fingolimod in Lung Cancers
NCT06424067
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Small-cell Lung Cancer
Interventions
DRUG:
Fingolimod 0.5 milligram (mg) [Gilenya]
Sponsor
Medical University of South Carolina